Testing effectiveness (Phase 2)Not Yet RecruitingNCT07694297
What this trial is testing
Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure
Who this might be right for
Acute Decompensation of Liver CirrhosisEstablished Acute-on-Chronic Liver Failure
Genfit 16